The authors reported a significant increase of MR signals in BT474 HER-2+ tumor-bearing mice 24h after injection, compared to non-functionalized NPs, indicating specificity scFv versus HER-2 overexpressing cells/tumors [136]. Here, ERBB2 is linked to neoplasm.